Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (3r,5as,6r,8as,9r,12s,12ar)-3,6,9-trimethyloctahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10(3h)-one
2. Arteannuin
3. Artemisinine
4. Artemisininum
5. Huanghuahaosu
6. Qing Hao Su
7. Qinghaosu
8. Quing Hau Sau
9. Quinghaosu
1. Qinghaosu
2. 63968-64-9
3. Huanghuahaosu
4. Artemisinine
5. Artemisine
6. (+)-artemisinin
7. Artemisinina
8. Artemisininum
9. Artemisinin [inn]
10. Qing Hau Sau
11. Nsc 369397
12. Chebi:223316
13. Octahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano(4,3-j)-1,2-benzodioxepin-10(3h)-one
14. 9rmu91n5k2
15. Qinghosu
16. Quing Hau Sau
17. Astemisinin
18. (1r,4s,5r,8s,9r,12s,13r)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-one
19. (3r,5as,6r,8as,9r,12s,12ar)-3,6,9-trimethyloctahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10(3h)-one
20. (3r,5as,6r,8as,9r,12s,12ar)-octahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano(4,3-j)-1,2-benzodioxepin-10(3h)-one
21. Qing Hau Su
22. Qinghaosu [chinese]
23. Artemisinine [french]
24. Artemisininum [latin]
25. Artemisinina [spanish]
26. (+)-arteannuin
27. Qing Hau Sau [chinese]
28. Mfcd00081057
29. Artemisia Annua L., Extract
30. (1r,4s,5r,8s,9r,12s,13r)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecan-10-one
31. (3r,5as,6r,8as,9r,12s,12ar)-3,6,9-trimethyloctahydro-3,12-epoxypyrano(4,3-j)(1,2)benzodioxepin-10(3h)-one
32. (3r,5as,6r,8as,9r,12s,12ar)-octahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano[4,3-j]-1,2-benzodioxepin-10(3h)-one
33. 1,5,9-trimethyl-(1r,4s,5r,9r,12s,13r)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-one
34. Smr000578089
35. Sr-01000802560
36. Gnf-pf-5341
37. Artemsinin
38. Brn 4194670
39. Unii-9rmu91n5k2
40. Artemesinin
41. Artesin
42. Nsc-369397
43. Qinghaosu,artemisinine
44. Spectrum_001351
45. Artemisinin [mi]
46. Prestwick0_000498
47. Prestwick1_000498
48. Prestwick2_000498
49. Prestwick3_000498
50. Spectrum2_001512
51. Spectrum3_001549
52. Spectrum4_000721
53. Spectrum5_001098
54. Artemisinin [inci]
55. Ec 700-290-5
56. Artemisinin [mart.]
57. Schembl60304
58. Artemisinin [usp-rs]
59. Artemisinin [who-dd]
60. Artemisinin [who-ip]
61. Bspbio_000395
62. Bspbio_002998
63. Kbiogr_000982
64. Kbioss_001831
65. Mls001097650
66. Mls001304036
67. Mls002153846
68. Divk1c_000656
69. Spbio_001583
70. Spbio_002316
71. Bpbio1_000435
72. Chembl269671
73. Gtpl9954
74. Dtxsid2040652
75. Kbio1_000656
76. Kbio2_001831
77. Kbio2_004399
78. Kbio2_006967
79. Kbio3_002498
80. Ninds_000656
81. Hms2090i17
82. Hms2096d17
83. Hms2267n09
84. Hms3269l13
85. Hms3413p13
86. Hms3677p13
87. Hms3713d17
88. Pharmakon1600-01503042
89. 3,12-epoxy-12h-pyrano[4,3-j]-1,2-benzodioxepin-10(3h)-one, Octahydro-3,6,9-trimethyl-, (3r,5as,6r,8as,9r,12s,12ar)-
90. Bcp02096
91. Hy-b0094
92. Zinc8143788
93. Artemisininum [who-ip Latin]
94. Bdbm50088447
95. Nsc758216
96. Akos024457231
97. Ccg-220498
98. Cs-1794
99. Db13132
100. Lmpr0103190003
101. Nsc-758216
102. Idi1_000656
103. (3r,5as,6r,8as,9r,12s,12ar)-3,6,9-trimethyloctahydro-12h-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10(3h)-one
104. 3,12-epoxy-12h-pyranol(4,3-j)-1,2-benzodioxepin-10(3h)-one, Octahydro-3,6,9-trimethyl-, (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12ar*)-(+)-
105. As-12692
106. S1282
107. 968a649
108. Q426921
109. Sr-01000802560-2
110. Sr-01000802560-3
111. Sr-01000802560-4
112. Brd-k13112821-001-08-3
113. Brd-k13112821-001-17-4
114. 2ab44f63-5d0f-424a-aa3f-24062f9c1ced
115. (3r,5as,6r,8as,9r,12s,12ar)-3,6,9-trimethyloctahydro-3,12-epoxypyrano(4,3-j )-1,2-benzodioxepin-10(3h)-one
116. (3r,5as,6r,8as,9r,12s,12ar)-3,6,9-trimethyloctahydro-3h-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10(12h)-one
| Molecular Weight | 282.33 g/mol |
|---|---|
| Molecular Formula | C15H22O5 |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 0 |
| Exact Mass | 282.14672380 g/mol |
| Monoisotopic Mass | 282.14672380 g/mol |
| Topological Polar Surface Area | 54 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 452 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01B - Antimalarials
P01BE - Artemisinin and derivatives, plain
P01BE01 - Artemisinin
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
67
PharmaCompass offers a list of Artemisinin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Artemisinin manufacturer or Artemisinin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Artemisinin manufacturer or Artemisinin supplier.
A ATM; manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ATM;, including repackagers and relabelers. The FDA regulates ATM; manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ATM; API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ATM; manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A ATM; supplier is an individual or a company that provides ATM; active pharmaceutical ingredient (API) or ATM; finished formulations upon request. The ATM; suppliers may include ATM; API manufacturers, exporters, distributors and traders.
click here to find a list of ATM; suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
ATM; Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ATM; GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right ATM; GMP manufacturer or ATM; GMP API supplier for your needs.
A ATM; CoA (Certificate of Analysis) is a formal document that attests to ATM;'s compliance with ATM; specifications and serves as a tool for batch-level quality control.
ATM; CoA mostly includes findings from lab analyses of a specific batch. For each ATM; CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ATM; may be tested according to a variety of international standards, such as European Pharmacopoeia (ATM; EP), ATM; JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ATM; USP).
